Palynziq
NDC 68135-058, pegvaliase-pqpz, injection, solution, from BioMarin Pharmaceutical Inc..
- Product NDC
- 68135-058
- Status
- Listed
- Labeler
- BioMarin Pharmaceutical Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761079
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68135-058 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEGVALIASE2.5 mg/.5mL
Pharmacologic classes
Phenylalanine Ammonia-Lyase [CS]; Phenylalanine Metabolizing Enzyme [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68135-058-90 | 68135005890 | 1 SYRINGE in 1 CARTON (68135-058-90) / .5 mL in 1 SYRINGE (68135-058-89) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6dba844a-db02-44f8-8593-ce497ed9406c
Use it
Look up 68135-058 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68135-058 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68135-058. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.